Bioengineering

​​​​​​​Rice Biotech Launch Pad accelerator aims to rapidly turn medical and health discoveries into cures

Rice University today introduced the Rice Biotech Launch Pad, a Houston-based accelerator focused on expediting the translation of the university’s health and medical technology discoveries into cures.

Lab Notes for Sept. 11, 2023

SCI Summer Research Colloquium awards; Applied physics students study in France

Smart fabrics’ informed touch can tell you where to go

Rice U. engineers developed a lightweight, wearable textile-based device that can deliver complex haptic cues, enabling a user to perform open-world navigation tasks. The device is resilient to regular daily use, withstanding multiple cycles of washing and other damage and repair without loss of function.

Michael King, Cynthia Reinhart-King to join Rice engineering faculty

Two leading experts in the biomedical engineering field, Michael King and Cynthia Reinhart-King, whose research programs have advanced the understanding and treatment of cancer and other diseases, will join the Rice University faculty next year.

Rice welcomes delegation from India

In order to deepen and broaden the partnership between Rice University and the Indian Institute of Technology Kanpur (IITK), Rice Global recently welcomed a delegation from the institute to the university for a day-long meeting.

Protective particles allow engineered probiotics to report gut disease

Rice U. bioengineers developed a platform that enhances survival and function of probiotics engineered to diagnose inflammatory bowel disease in animals. The technology holds promise for minimally invasive disease monitoring and advanced smart therapeutics.

Rice establishes 3-year partnership with Indian Institute of Technology Kanpur

Rice University and the Indian Institute of Technology Kanpur have taken an important next step in their strategic research and education partnership with the announcement of the first recipients of the Rice-IITK Strategic Collaboration Award program. 

Weaker transcription factors are better when they work together

Rice bioengineer Caleb Bashor and colleagues have developed a generalizable method to address “off-target” gene activation, a significant problem in the field of synthetic biology. Taking a cue from nature, the researchers showed they could all but eliminate the activation of off-target genes by designing weak transcription factors that cooperatively assemble.

Cost-effective jaundice testing developed for low-resource hospitals

The Rice360 Institute for Global Health Technologies has validated the accuracy of its latest testing technology for newborn jaundice. BiliDx addresses a critical gap in the availability of accurate, affordable, point-of-care jaundice testing in low-resource hospitals.

Rice U. program in Costa Rica promotes medical innovation

Rice University’s Global Medical Innovation program combines engineering, business and clinical training to help students solve real-world medical needs.

New software designs optimized, personalized treatments for movement impairments

A team of Rice University engineers has launched open-source software that constructs and uses personalized computer models of how individual patients move to optimize treatments for neurologic and orthopedic mobility impairments.

Rice researchers earn prestigious Defense Department grants

Rice professors Qimiao Si and Jeffrey Tabor are recipients of prestigious 2023 Vannevar Bush Faculty Fellowships from the Department of Defense.

Four Rice undergraduates latest Owls to win coveted Goldwater Scholarship

Rising Rice seniors Maria Hancu, Alex Lin, Ryan Wang and Ruofeng “Charlie” Liu are the latest Owls to win the coveted Goldwater Scholarship, one of the most prestigious honors bestowed each year upon pioneering STEM undergraduates across the country planning to pursue doctoral degrees.

NIH grant backs Rice lab’s sickle cell disease research

Rice University bioengineer Gang Bao and his team have won a grant from the National Institutes of Health to address critical questions surrounding the safety and efficacy of using gene editing to treat sickle cell disease.

Rice chemist wins $3.2M National Cancer Institute grant

Rice University chemist Han Xiao has won a $3.2 million research project (R01) grant from the National Cancer Institute to develop the first tissue-specific epigenetic inhibitor drug to treat bone metastasis.